News
Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation March 29, 2022 08:05 AM Eastern Daylight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback